Marc R. Larochelle MD, MPH
Associate Professor, General Internal Medicine
801 Massachusetts Ave | (617) 414-7399marc.larochelle@bmc.org
marcl@bu.edu
Sections
General Internal Medicine
Centers
Clinical Addiction Research and Education Unit
Biography
Marc Larochelle is a general internist and clinical investigator specializing in addiction medicine at BMC and an assistant professor of medicine at BUSM. Larochelle's clinical and research interests focus on the safety of opioid prescribing and the recognition and treatment of opioid use disorders. As a health services researcher, Larochelle aims to leverage insights from large data sources and translate the findings into interventions that improve the quality and value of health care delivered. His special interests are Primary Care and Addiction Medicine.
Education
Medicine-Internal, MD, University of Pittsburgh School of Medicine
Clinical Evaluation/Research, MPH, Harvard School of Public Health
Biomedical Engineering, BSE, Duke University
Publications
Hsu HE, Lodi S, Yan S, Bovell-Ammon BJ, Christine PJ, Tilhou AS, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz JM, Walley AY, Larochelle MR. Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment. JAMA Netw Open. 2026 Jul 01; 9(7):e2623280. PMID: 42446876.
Published on 7/1/2026Hall LC, Donohue JM, LaRochelle M, Rossom RC, Wang X, Afshar M, Gellad WF, Groenwold RHH, Han B, Jones CM, Lo-Ciganic WH, Lodi S, Marshall BDL, McLeman BM, Lambert-Harris CA, Saunders EC, Marsch LA. Methodological innovations to advance substance use disorder research: Proceedings of a NIDA workshop on target trial emulation and translational testing of digital health tools. J Subst Use Addict Treat. 2026 Jul 01; 190:210065. PMID: 42385937.
Published on 6/23/2026Adams RS, Reif S, Mohamed Y, Stewart MT, LaRochelle MR, Heaphy D, Corrigan JD, Khorassani FS, Morgan JR. Alcohol use disorder diagnoses among commercially insured US adults from 2016 to 2023, by disability status and sex. Drug Alcohol Depend Rep. 2026 Sep; 20:100461. PMID: 42440433.
Published on 6/12/2026Walley AY, Cheng DM, Vandergrift N, Larochelle M, Holloway J, Brown JL, Chandler R, Fanucchi LC, Feaster DJ, Freeman PR, Hunt T, Lofwall MR, Knudsen HK, Nunes EV, Oga E, Oyler DR, Samet JH, Villani J, Walsh SL, Winhusen TJ. The association between naloxone distribution, buprenorphine treatment and retention and incident high-risk opioid prescribing with opioid overdose death in Kentucky, Massachusetts, New York and Ohio, United States: An exploratory community-level cohort study of data from the HEALing Communities Study. Addiction. 2026 Jun 12. PMID: 42283399.
Published on 4/30/2026Chhatwal J, Sahinkoc M, Chen Q, Dowd W, Xiao J, Zarkin GA, Aldridge A, Barocas JA, Cerdá M, Fareed N, Frazier LA, Hyder A, Keyes KM, Knott CE, LaRochelle M, Linas BP, Oga E, Roberts SM, Samet JH, Schackman BR, Seiber EE, Starbird LE, Villani J, Knudsen AB, Barbosa C. Cost-effectiveness of community-based interventions for reducing opioid overdose and non-overdose deaths: simulation modeling of HEALing Communities Study. Lancet Reg Health Am. 2026 Jul; 59:101480. PMID: 42099551.
Published on 4/18/2026Weinstein ZM, Jadovich E, Drainoni ML, LaRochelle M, Yan S, Lee J, Bettano A, Beers D, Walley AY, Samet JH. Implementation of addiction consult services and bridge clinics in the HEALing communities study in Massachusetts. Drug Alcohol Depend. 2026 Jul 01; 284:113165. PMID: 42033894.
Published on 4/11/2026Sariahmed K, Gradus J, Edwards RR, Garcia R, Jin W, Morone NE, Rosellini A, Shiner B, LaRochelle M. The association of PTSD with burden of chronic overlapping pain conditions. Gen Hosp Psychiatry. 2026; 100:193-195. PMID: 41985380.
Published on 4/9/2026Wu E, Balise R, Katz B, Harris D, Bullard M, Fareed N, Larochelle M, Villani J. Building Public Health Data Dashboards: Tutorial Playbook. JMIR Public Health Surveill. 2026 Apr 09; 12:e83157. PMID: 41955547.
Published on 4/1/2026Cordes J, Bauer C, Bernson D, Larochelle MR, Li W, Cao J, Dammann O, Stopka TJ. The All-Payer Claims Database After the Gobeille Supreme Court Decision: Assessing the Impact on Fatal Opioid-Related Overdose Research. Health Serv Res. 2026 Apr; 61(2):e70097. PMID: 41796274.
Published on 3/5/2026Barbosa C, Chen Q, Sahinkoc M, Zarkin GA, Dowd W, Villani J, Barocas JA, Cerdá M, Chatterjee A, Fareed N, Hyder A, Keyes KM, Larochelle MR, Linas BP, Roberts SM, Schackman BR, Seiber E, Wakeman SE, Knudsen AB, Chhatwal J. Impact of enhanced practices on opioid overdose deaths: A community-based modeling approach. Addiction. 2026 Jul; 121(7):1747-1760. PMID: 41786317.
Media Mentions
Published on 9/7/2022
Some Patients on Opioids Shouldn’t Have to Taper Off
Published on 8/15/2022
Long-Term Opioid Tapering Does Not Benefit Suicide, Overdose Risks
Published on 9/28/2021
Opioid Overdose Deaths Rise Among Black Americans
Published on 9/20/2021
Opioid Overdose Death Rates Worsening for Non-Hispanic Blacks
Published on 9/17/2021
Opioid Overdose Death Rates Are Rising Among Black Americans
Published on 9/15/2021
How Overdose Surged for Black People as It Held Steady for Whites
Published on 9/15/2021
Researchers Call for Antiracist Approach to Address Disparities In Overdose Deaths
Published on 9/13/2021
Fatal Opioid ODs Keep Rising in Black Americans
Published on 9/13/2021
Fatal Opioid ODs Keep Rising in Black Americans
Published on 9/10/2021
Disparities in Opioid Overdose Deaths Are Worsening for Black Americans
View full list of 28 media mentions.